发明名称 リポタンパク質製剤及びその製造方法
摘要 A reconstituted high density lipoprotein formulation having relatively low toxicity comprises an apolipoprotein such as ApoAI or fragment thereof, a lipid and a detergent at a level which is about 5-50% of that which would normally cause liver toxicity upon administration to a human. The lipid is optimally phosphatidylcholine at about 30-50 g/L and the molar ratio of apolipoprotein:lipid is optimally in the range 1:40 to 1:75. The formulation is useful for treating diseases or conditions such as cardiovascular disease, hypercholesterolaemia and hypocholesterolaemia inclusive of acute coronary syndrome (ACS), atherosclerosis and myocardial infarction.
申请公布号 JP5989641(B2) 申请公布日期 2016.09.07
申请号 JP20130516907 申请日期 2011.06.30
申请人 シーエスエル、リミテッド 发明人 サミュエル・ライト;マルティン・インボーデン;ラインハルト・ボリ;マルセル・ヴェルクリ
分类号 A61K38/00;A61K31/575;A61K31/685;A61P3/06;A61P9/00;A61P9/10;A61P43/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址